Company Overview and News

to your dashboard

Headline News

2018 Strategic Outlook: Will Fortune Favor The Bold In Biotech?

1h seekingalpha
Significant scientific and technological breakthroughs, combined with unabated M&A appetite and tax reform, provide fertile ground for biotech gains in 2018. (302-0)

Road To Financial Independence: My December 88-Stock Portfolio Review

2018-01-15 seekingalpha
The year closed with a bang, with stock markets rallying strong, dividend income rising and more buying. (367-2)

The Toxicity Of Geron's Imetelstat May Lead To Accelerated FDA Approval

2018-01-12 seekingalpha
Median survival for patients taking Imetelstat may already exceed double and may soon exceed triple the expected timeline for patients admitted into the iMbark trial. (53-3)

Trading The Coming Earnings Hit On Apple

2018-01-12 seekingalpha
By now, you are all long up the wazoo with shares of Apple (AAPL). How would you respond if I told you that Steve Jobs’ creation is about to take a gigantic $33 billion earnings hit? My guess is that you’d jump off the nearest bridge, slit your wrists, or at the very least, come down with a severe case of Montezuma’s Revenge. I can pretty much guarantee you that such a blockbuster announcement is headed your way in the coming weeks, if not days. (251-0)

Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo

2018-01-12 zacks
The Dow endured a volatile week during which the index hit a fresh record high. A fall in bank shares led to losses for the index on Monday. The index slipped on Tuesday following positive news from a major component. Surging treasury yields led to losses for the index on Wednesday. Ultimately, the index surged to a record high on Thursday following investor optimism over economic growth. Last Week’s Performance The Dow gained 0. (276-0)

Best Index Funds For 2018

2018-01-12 seekingalpha
This article contains some of the best passively managed funds you can add to your portfolio. (71-0)

Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

2018-01-12 zacks
Abbott (ABT - Free Report) has been hogging the limelight for developments in the flagship, sensor-based continuous glucose monitoring (CGM) system — FreeStyle Libre System. (19-0)

Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference

2018-01-12 zacks
Focus this week was on the 36th annual JPMorgan healthcare conference where several biotech and pharma companies provided a preliminary look at their results for 2017 and also provided pipeline updates as well as their outlooks for 2018. Recap of the Week’s Most Important Stories Key Takeaways from JPMorgan Healthcare Conference: Several pharma companies were present at the 36th annual JPMorgan healthcare conference, the largest and most informative healthcare investment symposium in the industry. (18-0)

How To Retire At 62 On A Meager Million

2018-01-12 seekingalpha
Many older workers grapple with this question every day. Often, they turn to Seeking Alpha for answers. Today, retirees need a clear plan for their future. (47-0)

Dale's 2017 Portfolio Review: Let The Good Times Roll

2018-01-12 seekingalpha
2017 was certainly an uneventful year for North American investments and unfortunately The Toronto Blue Jays. (353-0)

Jeff Sessions is Taking Some Steam Out of the Marijuana Stocks Rally

2018-01-11 investorplace
Australia earlier this month joined the growing list of nations that have legalized medical marijuana. And as more countries are added to the list — as well as a smaller number approving or decriminalizing recreational use — many investors see upside remaining in cannabis-related stocks despite a recent rally. (141-0)

After a Solid Start, What Awaits Dow ETF in Q4 Earnings?

2018-01-11 zacks
The Wall Street had a sizzling start to 2018 as Trump's tax overhaul bolstered the optimism over strong corporate earnings and an improving economy. With the Q4 earnings season underway, investors are betting that the new tax legislation will result in big savings for the corporations, giving a boost to earnings. The Dow Jones Industrial Average has been the biggest beneficiary of the Trump era and thus, its proxy version, SPDR Dow Jones Industrial Average ETF DIA, is in the spotlight. (32-0)

Big Pharma CEOs Speak About Impact of Tax Reform on M&A

2018-01-11 zacks
Quite a few pharmaceutical industry mergers – including some large deals - may be in the cards in 2018 now that the tax reforms are in place. The tax bill was signed into law by U.S. President Donald Trump in December last year (297-1)

Top Reasons To Put Your Money In AbbVie In 2018

2018-01-10 seekingalpha
The company seems to be on the verge of witnessing a solid upsurge in demand for its oncology drugs in 2018. (166-0)

A Sluggish Spine Market Keeping The Pressure On NuVasive

2018-01-10 seekingalpha
A softer than expected spine market and ongoing pressure in areas like biologics have continued to pressure NuVasive's revenue growth. (23-0)

CUSIP: 478160104